| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―15 |
Increased mortality in myocardial infarction after COVID-19 infection: more and more convincing data |
Franck Boccara, Laurie Soulat-Dufour, Ariel Cohen |
| 2 |
[GO] |
2026―Jun―11 |
Impact of coronavirus disease 19 (COVID-19) pandemic on age differences of acute coronary syndromes admissions and in-hospital outcomes |
L Simoni, A Ceka, M Gina, E Tafaj, K Ziu, T Gega, I Gogo, I Alimehmeti, A Dibra |
| 3 |
[GO] |
2026―Jun―11 |
Digital health literacy for cardiovascular prevention: lessons from the COVID-19 pandemic among ACS patients in a southern european region |
K Bouchalaki, E Zacharis, S Petousis, E Foukarakis, M Pitarokoilis, K Pitsikakis, J Kipriotakis, G Kochiadakis, E Simantirakis, I Tsiligianni, M Marketou |
| 4 |
[GO] |
2026―Jun―11 |
Long-term cardiopulmonary fitness and respiratory muscle recovery 12 months after COVID-19 |
C Luz Goulart, V M Vinicius Maldaner, M M Mauricio Milani, J M Juliana Milani, R F B Robson Fernando Borges, L T F Leandro Tolfo Franzoni, F F Filipe Ferrari, A B S Audrey Borghi-Silva, L P C Lawrence P Cahalin, G F B C Graziella Fb Cipriano, G C J Gerson Cipriano Junior, R S Ricardo Stein |
| 5 |
[GO] |
2026―May―31 |
Cardiac Troponins and SARS-CoV-2: Subclinical Myocardial Injury as he Long Shadow of the Pandemic |
Vincenzo Castiglione, Aldo Clerico, Michele Emdin |
| 6 |
[GO] |
2026―May―21 |
Impact of SARS-CoV-2 infection on subclinical myocardial injury in the general population: the Trøndelag Health Study |
Torbjørn Omland, Kristian Hveem, Christos Varounis, Magnus Nakrem Lyngbakken |
| 7 |
[GO] |
2026―Mar―27 |
Using population-wide electronic health records for timely contemporary assessment of cardiovascular disease risk prediction model performance: COVID-19 impact on the SCORE2 models |
Carmen Petitjean, Spencer J Keene, Thomas Bolton, Alexia Sampri, Genevieve Cezard, Samantha Ip, Fionna Chalmers, Anna J Stevenson, Stelios Boulitsakis Logothetis, Spiros Denaxas, Kamlesh Khunti, Elena Raffetti, Lois G Kim, Naveed Sattar, Sarah H Wild, Emanuele Di Angelantonio, Stephen Kaptoge, Angela Wood, Lisa Pennells |
| 8 |
[GO] |
2025―Nov―09 |
Risk of new-onset heart failure and heart failure exacerbations following COVID-19, influenza, or respiratory syncytial virus hospitalization |
Liang En Wee, Enoch Xueheng Loy, Jinghao Nicholas Ngiam, Jue Tao Lim, Calvin J Chiew, Russell Jingxian Li, Yew Woon Chia, Shir Lynn Lim, Jonathan Yap, Raymond Wong, Khung Keong Yeo, Derek J Hausenloy, Mark Yan Yee Chan, David Chien Boon Lye, Kelvin Bryan Tan |
| 9 |
[GO] |
2025―Sep―05 |
Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, the Association of Cardiovascular Nursing & Allied Professions, the European Association of Percutaneous Cardiovascular Interventions, and the Heart Failure Association of the ESC |
Vassilios S Vassiliou, Vasiliki Tsampasian, Maria Luiza Luchian, Flavio D’Ascenzi, Fabrizio D’Ascenzo, Marc R Dweck, Javier Escaned, Sabiha Gati, Martin Halle, Konstantinos C Koskinas, Lis Neubeck, Michael Papadakis, Steffen E Petersen, Arsen Ristic, Marco Metra, Giuseppe Biondi-Zoccai |
| 10 |
[GO] |
2025―Aug―26 |
Recent COVID-19 and mortality after myocardial infarction: a Danish nationwide cohort study |
Katrine D Brodersen, Sinna P Ulrichsen, Signe Sørup, Lars Pedersen, Reimar W Thomsen, Henrik T Sørensen, Morten Schmidt |
| 11 |
[GO] |
2025―May―19 |
Cardiopulmonary recovery in pediatric patients following multisystem inflammatory syndrome in children: a prospective cohort study 9 months after SARS-CoV-2 infection |
G Merati, G C Corti, S Rampichini, V Volpi, C Agutoli, S Castelletti, G V Zuccotti, V Calcaterra, P Castiglioni, D Formenti, F Esposito, E Roveda, S Mannarino |
| 12 |
[GO] |
2025―May―19 |
Validation of cardiovascular disease risk prediction models using population-wide electronic health records for England post COVID-19 pandemic: the SCORE2 family-of-models |
C Petitjean, S J Keene, T Bolton, A Sampri, S Boulitsakis Logothetis, G Cezard, F Chalmers, A Stevenson, S Ip, N Sattar, S Wild, E Di Angelantonio, S Kaptoge, L Pennells, A M Wood |
| 13 |
[GO] |
2025―May―19 |
Markers of atherosclerosis following COVID-19 infection |
R Xuereb, S Fava, C J Magri |
| 14 |
[GO] |
2025―May―19 |
Association of pre-pandemic estimated cardiorespiratory fitness and physical activity levels with COVID-19 incidence and hospitalization: the HUNT study |
E Eriksen, J N Javaid Nauman, U W Ulrik Wisloeff, T O Torbjoern Omland, D S Dorthe Stensvold |
| 15 |
[GO] |
2025―May―19 |
Determinants of arterial stiffness in a population exposed to COVID-19 |
R Xuereb, S Fava, C J Magri |
| 16 |
[GO] |
2024―Jun―14 |
The effectiveness of antihypoxic and cardioprotective drug in the rehabilitation of patients with COVID-19 associated pneumonia |
S Bondarev, I Stulikova, M Nasrulaev |
| 17 |
[GO] |
2024―Jun―14 |
Exploring predictors and correlations of COVID-19 impact in revascularized patients |
O Musayev, R Dashdemirov, F Ibrahimov, K Musayev, Z Alimli, M Gafarova, N Mushtagzadeh |
| 18 |
[GO] |
2024―Jun―14 |
Association of education and non-partnered relationship with all-cause and cardiovascular mortality before and during the COVID-19 pandemic in a prospective population-based cohort study |
M Bobak, A Bartoskova Polcrova, H Pikhart |
| 19 |
[GO] |
2024―Jun―14 |
microRNA profile of inflammatory response in COVID-19 participants |
S L Russell, C Lozahic, M Rahman, N Okwose, S M Raleigh, G Mcgregor, H Maddock, P Banerjee, D G Jakovljevic, H Sandhu |
| 20 |
[GO] |
2024―Jun―14 |
Increased incidence of arrhythmias, heart failure and thrombosis in COVID-19 patients after the first 3 months post-infection: a population-based cohort study |
I R Degano, C Tintore, A Camps-Vilaro, I Subirana, R Elosua, J Marrugat |
| 21 |
[GO] |
2024―Jun―14 |
Association of cardiorespiratory fitness measured by cardiopulmonary exercise testing with covid-19 positivity: a prospective register-based cohort study |
E A E Espen Alexander Eriksen, D S Dorthe Stensvold, J N Javaid Nauman, U W Ulrik Wisloeff, T O Torbjoern Omland |
| 22 |
[GO] |
2024―Jun―14 |
The impact of cardiorespiratory fitness on COVID-19 related outcomes: the ETHOS Study |
J Myers, P Kokkinos, C Cadenas-Sanchez, A Liappis, N Goraya, A Weintrob, A Pittaras, A Ladas, M Heimall, C Faselis |
| 23 |
[GO] |
2024―Jun―14 |
Pro-inflammatory cytokines are elevated two-years after acute severe COVID-19: a pre-vaccine, two-years, five-point longitudinal assessment of individuals with Long COVID |
C Luz Goulart, A B S M Alex Bezerra Da Silva Maciel, A G R Anna Gabriela Rezende, J V Jefferson Valente, B M S Bernardo Maia Da Silva, V S Vanderson Sampaio, A G Allyson Guimaraes, G P T A Guilherme Peixoto Tinoco Areas, F F A V Fernando Fonseca De Almeida E Val |
| 24 |
[GO] |
2024―Jun―14 |
Muscle oxygenation kinetics in Long COVID-19: Illness severity and clinical implications |
C Luz Goulart, R F B Robson Fernando Borgesa, C C C H S Claudia Cristina Conde Holanda Sobral, T B Thomas Beltrame, M M Mauricio Milani, G C J Gerson Cipriano Junior, A C P S Ana Cleides Pereira Dos Santos, R S Ricardo Stein, F B Fabricio Braga, L E F R Luiz Eduardo Fonteles Ritt |
| 25 |
[GO] |
2024―Jun―14 |
Higher inflammatory cytokines in long-covid with cardiovascular symptoms after acute severe COVID-19? A two-year, pre-vaccine, longitudinal, exploratory, nested cohort |
F Fonseca De Almeida E Val, C L G Cassia Da Luz Goulart, A B S M Alex Bezerra Da Silva Maciel, J V Jefferson Valente, V S Vanderson Sampaio, A G Allyson Guimaraes, G P T A Guilherme Peixoto Tinoco Areas |
| 26 |
[GO] |
2024―Jun―14 |
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study |
S Polo-Alonso, A Camps-Vilaro, I R Degano, R Marti-Lluch, M Pinsach-Abuin, E Selga, E Puigdecanet, M Pedrerol-Alvarez, M Puigmule, A Perez, I Subirana, R Elosua, R Brugada, R Ramos, J Marrugat |
| 27 |
[GO] |
2024―Jun―14 |
Daily-life and work activities are more impaired in individuals with long covid who present cardiopulmonary symptoms: preliminary results from a cross-sectional assessment |
F Fonseca De Almeida E Val, C L G Cassia Da Luz Goulart, J V Jefferson Valente, A G R Anna Gabriela Rezende, B M S Bernardo Maia Da Silva, A V N Alexandre Vilhena Neto, G P T A Guilherme Peixoto Tinoco Areas |
| 28 |
[GO] |
2024―Jun―14 |
Dysfunctional breathing in long COVID: inter-rater agreement and clinical characteristics |
M Milani, J S Neiva, A D Silveira, J G P O Milani, G Cipriano Junior, G F B Cipriano |
| 29 |
[GO] |
2024―Mar―04 |
Behind the shadows: Bringing the cardiovascular secrets of long COVID into light |
Joseph Adu-Amankwaah |
| 30 |
[GO] |
2024―Feb―20 |
Cardiovascular disease as part of Long COVID: A systematic review |
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, Elena Cavarretta, Maciej Dębski, Sabiha Gati, Dominique Hansen, Nicolle Kränkel, Konstantinos Koskinas, Josef Niebauer, Luigi Spadafora, Manuel Frias Vargas, Giuseppe Biondi-Zoccai, Vassilios S Vassiliou |
| 31 |
[GO] |
2024―Jan―20 |
Cardiopulmonary limitations in young Long Covid patients: A case control study |
Geza Halasz, Francesco Di Spigno, Davide Donelli, Alessandro Giacani, Luca Moderato, Davide Lazzeroni, Leonardo De Luca, Massimo Piepoli |
| 32 |
[GO] |
2023―Dec―14 |
Correction to: Vaccines and variants: an update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19 |
|
| 33 |
[GO] |
2023―May―24 |
Enlarged dimensions of cardiac chambers and the root of the aorta as a significant cardiovascular impact of pandemic COVID-19: a population-based study |
M Chlabicz, M Dubatowka, J Jamiolkowski, A Szum-Jakubowska, S Solomacha, N Zieleniewska, P Sowa, S Lawicki, A Szpakowicz, K Ptaszynska-Kopczynska, A M Moniuszko-Malinowska, K A Kaminski |
| 34 |
[GO] |
2023―May―24 |
Telemonitoring of patients after COVID-19 hospitalization: study design and baseline characteristics |
M Hiddemann, K Koehler, L Riehle, S Prescher, C Butter, R Prondzinsky, S Winkler, V Moeller, S Spethmann, F Koehler |
| 35 |
[GO] |
2023―May―24 |
Impact of COVID-19 situation on non COVID myocardial infarction admissions |
H Del Castillo-Carnevali, J Alvarez, J Torres, S Magnani, M E Morante, A Sahuquillo, T Ripoll, V Peral, J M Gamez |
| 36 |
[GO] |
2023―May―24 |
Impact of COVID-19 situation on non COVID cardiological admissions |
H Del Castillo-Carnevali, J Alvarez, T O R R E S Joan, S Magnani, D Cremer, V Ruiz, M Alamar, M E Moranta, P Folgado, T Ripoll, J M Gamez |
| 37 |
[GO] |
2023―May―24 |
Variation in complexity weight values for heart failure admissions: the impact of COVID-19 situation |
H Del Castillo-Carnevali, A Sahuquillo, T Ripoll, J Torres, J Alvarez, D Cremer, B Coto, J M Gamez |
| 38 |
[GO] |
2023―May―24 |
The impact of COVID-19 pandemic on cardiovascular diseases hospitalization, management and mortality in Switzerland |
K Maung, P Marques-Vidal |
| 39 |
[GO] |
2023―May―24 |
Determinants of Hospitalisation and Intubation in COVID-19 Infection |
R A Xuereb, J Gatt, J Barbara, N Tabone Adami, J Darmanin, R Erasmi, R G Xuereb, C Barbara, S Fava, C J Magri |
| 40 |
[GO] |
2023―May―24 |
The impact of the COVID-19 pandemic on the quality of centre-based cardiac rehabilitation |
B Jug, J Trsan, M Novakovic, J Tasic, B Krevel, Z Fras, M Lainscak, J Farkas Lainscak |
| 41 |
[GO] |
2023―May―24 |
Prevalence and diagnostic significance of de-novo 12-lead electrocardiogram patterns following covid-19 infection in elite soccer players |
R Bhatia, A Malhotra, H Maclachlan, S Gati, S Marwaha, N Chatrath, S Fyyaz, R Cooper, J Daems, J Hattum, G Finocchiaro, R Stein, H Jorstad, M Papadakis, S Sharma |
| 42 |
[GO] |
2023―May―24 |
Prevalence of abnormal cardiovascular magnetic resonance findings in athletes recovered from COVID-19 |
V Tsampasian, R W Catumbela, E Androulakis, S Gati, M Papadakis, V S Vassiliou |
| 43 |
[GO] |
2023―May―24 |
Analysis of long-term cardiovascular outcomes of COVID-19. Artificial Intelligence model for risk evaluation |
A Hovornyan, T O Ilashchuk |
| 44 |
[GO] |
2023―May―24 |
Traditional media or chatbot: how can we reach older adults with the COVID-19 information they need? |
R Olszewski, K Cwiklinska, J Brzezinski, J Owoc, M Manczak, M Zaremba, T Targowski, K Jeziorski |
| 45 |
[GO] |
2023―May―24 |
Association of right and left atrial strain with laboratory, anthropometric and echocardiographic markers - the influence of COVID-19 pandemic |
M Dubatowka, M Chlabicz, P Sowa, J Jamiolkowski, S Solomacha, N Zieleniewska, M Lapinska, A M Moniuszko-Malinowska, K A Kaminski |
| 46 |
[GO] |
2023―May―24 |
The role of tele-rehabilitation in post-myocardial infarction populations during the covid-19 pandemic in a tertiary care centre |
K K K Kyaw |
| 47 |
[GO] |
2023―May―24 |
Alteration of circulating ACE2-network related miRNAs in patients with COVID-19 |
Z Wicik, C Eyileten, A Nowak, D Keshwani, S N Simoes, D C Martins Jr, K Klos, W Wlodarczyk, A Assinger, D Soldacki, A Chcialowski, J Siller-Matula, M Postula |
| 48 |
[GO] |
2023―May―24 |
Impact of telemedicine on treatment of diabetes mellites in patients with cardiovascular Disease during SARS-Cov-2 pandemic |
R Nakauchi, N Nishio, N Nishio, Y Fujii, Y Fujii, A Takahashi, A Takahashi, T Yamada, N Taniguchi, T Hata, S Nakajima, Y Takahashi |
| 49 |
[GO] |
2023―May―24 |
Effect of a home-based inspiratory muscle training program on functional capacity in post-discharged patients with long COVID: The InsCOVID trial |
C Albiach, E Dominguez, L Lopez, C Sastre, S Minguez, J Nunez, P Palau Sampio |
| 50 |
[GO] |
2022―Oct―16 |
Return to play after COVID-19 infection in child and adolescent athletes: Should Physician’s clearance always be required? |
Luis Serratosa |
| 51 |
[GO] |
2022―Oct―06 |
Vaccines and Variants: An update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19 |
Oliver O’Sullivan, Rienk Rienks, David Holdsworth, Constantinos H Davos, Martin Halle, Alexander Bennett, Gianfranco Parati, Norbert Guettler, Edward Nicol |
| 52 |
[GO] |
2022―Oct―06 |
Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccination |
Selma Tobudic, Keziban Uyanik-Ünal, Maximilian Koblischke, Lisa Schneider, Stephan Blüml, Florian Winkler, Helmuth Haslacher, Thomas Perkmann, Heinz Burgmann, Judith H Aberle, Stefan Winkler |
| 53 |
[GO] |
2022―Sep―05 |
Cardiac screening prior to return to play after SARS-CoV-2 infection: focus on the child and adolescent athlete: A Clinical Consensus Statement of the Task Force for Childhood Health of the European Association of Preventive Cardiology |
Flavio D’Ascenzi, Silvia Castelletti, Paolo Emilio Adami, Elena Cavarretta, María Sanz-de la Garza, Viviana Maestrini, Alessandro Biffi, Paul Kantor, Guido Pieles, Evert Verhagen, Monica Tiberi, Henner Hanssen, Michael Papadakis, Josef Niebauer, Martin Halle |
| 54 |
[GO] |
2022―Jul―07 |
The effect of smoking on exhaled carbon monoxide and arterial elasticity during prolonged surgical mask use in the COVID-19 era |
Ignatios Ikonomidis, Konstantinos Katogiannis, Kallirhoe Kourea, Kostelli Gavriella, Damianos Tsilivarakis, Vaia Lambadiari, Dimitrios Kouretas, Giuseppe Biondi-Zoccai |
| 55 |
[GO] |
2022―Jun―16 |
Impact of COVID-19 on young healthcare professionals |
Martin Bahls, Marwa H Gaber, Harald T Jorstad, Najat Mouine, Martijn Scherrenberg, Elena Marques-Sule |
| 56 |
[GO] |
2022―May―11 |
Physical activity and psychological status of hypertensive and healthy individuals: in the era of COVID-19 |
B Karaduz, YZ Sener, N Vardar Yagli, E Calik Kutukcu, L Tokgozoglu |
| 57 |
[GO] |
2022―May―11 |
Cardiac Rehabilitation during COVID-19 |
C Desira, G De Gray, J Fleri Soler, M Abela |
| 58 |
[GO] |
2022―May―11 |
Covid-19 and ischemic heart disease: clinical manifestations, biomarkers, treatment and follow-up |
V Tashchuk, R Nesterovska |
| 59 |
[GO] |
2022―May―11 |
Low prevalence of cardiac abnormalities in competitive athletes before the return-to-play after COVID-19 based on the italian strategy |
M Penza, D Filomena, L Birtolo, S Monosilio, A Serdoz, R Fiore, R Mango, E Lemme, M Squeo, F Fedele, G Gualdi, A Spataro, A Pelliccia, B Di Giacinto, V Maestrini |
| 60 |
[GO] |
2022―May―11 |
Nutrition guidelines compliance in cardiovascular disease patients attending a long-term exercise-based cardiac rehabilitation program during COVID-19 era |
M Linan Pinto, S Charneca, J Vasques, R Pinto, M Lemos Pires, M Borges, H Santa-Clara, A Abreu, C Sousa Guerreiro |
| 61 |
[GO] |
2022―May―11 |
Cardiorespiratory fitness assessment on active patients who kept attending their phase III exercise-based cardiac rehabilitation during the COVID-19 era |
J Lopes, R Pinto, M Borges, M Pires, A Nunes, J Brito, P Silva, I Ricardo, F Pinto, A Abreu |
| 62 |
[GO] |
2022―May―11 |
Cardiovascular disease after COVID-19 infection in elderly patients. Results of annual follow-up of a cohort of survivors |
D Aguila Gordo, J Piqueras Flores, J Martinez Del Rio, M Negreira Caamano, C Mateo Gomez, M Soto Perez, AF Cubides Novoa, A Moron Alguacil, M Munoz Garcia, E Blanco Lopez, P Soto Martin, D Salas Bravo, JM Arizon Munoz |
| 63 |
[GO] |
2022―May―11 |
Impact of COVID-19 infection on a physically active population: evaluation functional using the Cardiopulmonar Exercise Test (CPET) |
A Berenguel Senen, J Borrego Rodriguez, JR Godoy Lopez, A Gadella Fernandez, C De Cabo Porras, A Serrano Blanco, M Gallango Brejano, E Gigante Miravalles, MC Morante Perea, PL Cepas-Guillen, M Lazaro Salvador, ME Villasante Felix, F Fernandez-Vazquez, L Rodriguez Padial |
| 64 |
[GO] |
2022―May―11 |
Unhealthy behaviours of patients with cardiovascular diseases during the second COVID-19 lockdown in Northern Greece |
A Ioannidis, A Pechlevanis, M Paraskelidou, A Fragkiskou, V Giakoumi, D Lakias |
| 65 |
[GO] |
2022―May―11 |
Extend of unhealthy behaviours of patients with cardiovascular diseases during the second COVID-19 lockdown in Northern Greece: comparison between urban and rural residents |
A Ioannidis, A Fragkiskou, A Pechlevanis, M Paraskelidou, V Giakoumi, F Asmani |
| 66 |
[GO] |
2022―May―11 |
COVID-19 pandemia impact on patients included in heart rehabilitation programme |
B Coto Morales, EM Basabe Velasco, IM Gomez Sanchez, D Marti Sanchez, AF Marschall, FA Delgado Calva, HA Del Castillo Carnevalli, DJ Rodriguez Torres, MF Rodriguez Biezma, A Molinos, MA Rodriguez Gamero, MP Casanova Lopez, J Fuentes Pereiro, MA Sastre Perona, SA Alvarez Anton |
| 67 |
[GO] |
2022―May―11 |
Impact of a home-based cardiac rehabilitation program in heart failure during the COVID-19 pandemic |
C Schmidt, PG Basilio, S Magalhaes, A Alexandre, A Barreira, P Fernandes, F Ribeiro, M Santos |
| 68 |
[GO] |
2022―May―11 |
A retrospective observational study of face-to-face versus hybrid phase II cardiac rehabilitation program during COVID-19 pandemic |
N Santaularia, A Arnau, N Tora, A Ramirez-Morros, G Vazquez-Oliva |
| 69 |
[GO] |
2022―May―11 |
Implementing hybrid telerehabilitation following major cardiac surgery during COVID-19 pandemic in Hong Kong |
K F Wong, N Fu, KYY Fan, K Y Cheng, K L Wong, C Y Yung, C K L Ho, TWK Au |
| 70 |
[GO] |
2022―May―11 |
Acute coronary syndromes hospitalizations and in-hospital outcomes during and after the lockdown of corona virus disease 19 (COVID-19) pandemic outbreak |
L Simoni, I Alimehmeti, M Gina, A Ceka, E Tafaj, A Voci, A Panariti, F Xhafa, A Dibra, A Goda |
| 71 |
[GO] |
2022―May―11 |
Virtual cardiac rehabilitation during the COVID-19 pandemic: a tertiary site experience |
N Moulson, J Robinson, S Chan, D Cuff, A Ignaszewski, S Isserow, B Lau, N Ordano, L Sung, J Werry, C Taylor |
| 72 |
[GO] |
2022―May―11 |
Cardiac practice during the second year of COVID-19 pandemic: are we going back to normal? |
Z A Dakhil, F A Cader, TUG˘BA Oz, NUNZIA Borreli |
| 73 |
[GO] |
2022―May―11 |
Echocardiographic findings in COVID-19 patients with cardiovascular disease |
G Smyrnova, T Babkina |
| 74 |
[GO] |
2022―May―11 |
COVID-19 survivors are physically inactive with high levels of sedentary time, regardless of patient characteristics, disease severity or cardiac dysfunction |
BMA Van Bakel, FMA Van Den Heuvel, JL Vos, H Rotbi, EA Bakker, R Nijveldt, DHJ Thijssen, TMH Eijsvogels |
| 75 |
[GO] |
2022―May―11 |
Covid-19 survivors may have deterioration in frontal plane qrs-t angle and the other electrocardiogram parameters |
M S Kuyumcu, S Ulusan |
| 76 |
[GO] |
2022―May―11 |
Relationship between the spread of coronavirus disease 2019, social frailty and depressive symptoms in patients with heart failure |
S Shakuta, M Yamashita, K Kamiya, N Hamazaki, K Nozaki, S Uchida, T Noda, K Ueno, E Maekawa, M Yamaoka-Tojo, A Matsunaga, J Ako |
| 77 |
[GO] |
2022―May―11 |
Coronavirus-related stress, anxiety, and obsessive thinking in patients undergoing cardiac rehabilitation during the COVID19 pandemic |
B Jug, J Farkas Lainscak, N Sedlar, D Stojnic, M Lainscak |
| 78 |
[GO] |
2022―May―11 |
SARS-CoV-2 associated cardiac abnormalities in elite athletes: results from the prospective, longitudinal COMMIT cohort |
J Van Hattum, SM Verwijs, SE Davelaar, JJN Daems, SM Boekholdt, M Groenink, RN Planken, RD Van Luijk-Snoeks, AM Van Den Berg-Faay, MH Moen, CACM Wijne, AJ Nederveen, YM Pinto, AAM Wilde, HT Jorstad |
| 79 |
[GO] |
2022―May―11 |
Cardiovascular screening in olympic athletes before and after SARS-CoV-2 infection |
V Maestrini, D Filomena, L I Birtolo, S Monosilio, M Tatangelo, M Penza, A Serdoz, R Fiore, E Lemme, M R Squeo, F Fedele, G Gualdi, A Spataro, A Pelliccia, B Di Giacinto |
| 80 |
[GO] |
2022―May―11 |
SARS-CoV-2 infection and return-to-play in junior competitive athletes: is systematic cardiac screening needed? |
L Cavigli, M Cillis, V Mochi, F Frascaro, N Mochi, A Hajdarevic, A Roselli, M Capitani, F Alvino, C Lisi, GE Mandoli, S Valente, M Focardi, M Cameli, F D'ascenzi |
| 81 |
[GO] |
2022―May―11 |
Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up |
D Aguila Gordo, J Martinez Del Rio, J Piqueras Flores, M Negreira Caamano, C Mateo Gomez, M Soto Perez, D Salas Bravo, JM Arizon Munoz, AF Cubides Novoa, M Munoz Garcia, E Blanco Lopez, P Soto Martin, A Moron Alguacil |
| 82 |
[GO] |
2022―May―11 |
Genetic risk score for risk stratification of patients positive for SARS-CoV-2 virus. The CARGENCORS study |
A Camps-Vilaro, I R Degano, R Brugada, R Elosua, R Ramos, R Marti, I Subirana, X Nogues, JR Masclans, R Guerri, J Marin, H Tizon, B Vaquerizo, M Pinsach, J Marrugat |
| 83 |
[GO] |
2022―May―11 |
Physical and psychological reconditioning in long covid syndrome patients: results of a structured physical exercise program |
S Palermi, S Compagno, V Pescatore, E Brugin, G Tegon, M Sarto, R Marin, V Calzavara, M Nizzetto, M Scevola, C Albertin, A Biffi, F Giada |
| 84 |
[GO] |
2022―Feb―21 |
Exercise-induced Cardiac Troponin T Release in Veteran Athletes Recovered from COVID-19 |
Sylvan L J E Janssen, Vincent L Aengevaeren, Coen C W G Bongers, Geert Kleinnibbelink, Femke de Vries, Alma M A Mingels, Thijs M H Eijsvogels, Maria T E Hopman |
| 85 |
[GO] |
2022―Jan―24 |
Effects of exercise rehabilitation in patients with long COVID-19 |
Cristina Barbara, Piero Clavario, Vincenzo De Marzo, Roberta Lotti, Giulia Guglielmi, Annalisa Porcile, Carmelo Russo, Raffaele Griffo, Timo Mäkikallio, Arto Jorma Hautala, Italo Porto |
| 86 |
[GO] |
2022―Jan―03 |
Letter on Incidence and prognosis of COVID-19 amongst heart transplant recipients: a systematic review and meta-analysis |
Saeed Shoar |
| 87 |
[GO] |
2022―Jan―03 |
COVID-19 in heart transplant patients: is there a cause for concern? |
Huzaifa Ahmad Cheema, Abia Shahid |
| 88 |
[GO] |
2021―Sep―01 |
COVID-19 pandemic and cardiovascular disease: the double sentence |
Julien Vaucher |
| 89 |
[GO] |
2021―Jun―30 |
Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19 |
Benjamin J R Buckley, Stephanie L Harrison, Elnara Fazio-Eynullayeva, Paula Underhill, Ian D Jones, Nefyn Williams, Gregory Y H Lip |
| 90 |
[GO] |
2021―May―11 |
Blood pressure level and laboratory indicators of disease severity in patients with arterial hypertension and COVID-19 |
K Popov, A Novitskiy, Y Shvarts |
| 91 |
[GO] |
2021―May―11 |
COVID-19 era in long-term cardiac rehabilitation programs: how did physical activity and sedentary time change compared to previous years? |
M Lemos Pires, M Borges, R Pinto, I Ricardo, N Cunha, P Alves Da Silva, M Linan Pinto, C Sousa Guerreiro, FJ Pinto, H Santa-Clara, A Abreu |
| 92 |
[GO] |
2021―May―11 |
COVID-19 era in long-term cardiac rehabilitation programs: how was muscle strenght and lean mass affected in cardiovascular patients? |
M Borges, M Lemos Pires, R Pinto, G De Sa, I Ricardo, N Cunha, P Alves Da Silva, M Linan Pinto, C Sousa Guerreiro, FJ Pinto, A Abreu, H Santa-Clara |
| 93 |
[GO] |
2021―May―11 |
Physical activity and sedentary behaviour in cardiovascular disease patients during the COVID-19 lockdown in the Netherlands; a longitudinal cohort study |
BMA Van Bakel, EA Bakker, F De Vries, DHJ Thijssen, TMH Eijsvogels |
| 94 |
[GO] |
2021―May―11 |
Effects of COVID-19 lockdown on physical activity in coronary patients on a phase III cardiac rehabilitation program |
N Santaularia, A Arnau, N Tora, A Ramirez-Morros, G Vazquez-Oliva |
| 95 |
[GO] |
2021―May―11 |
During the Covid-19 lockdown, rural residence is associated to healthier lifestyle behaviours in patients with chronic coronary syndrom |
F Chague, A Cransac-Miet, M Boulin, M Saint-Jalmes, F Bichat, A Soudry, N Danchin, M Zeller, Y Cottin |
| 96 |
[GO] |
2021―May―11 |
HFrEF patient activity levels during COVID-19 lockdown: A comparison between physical activity questionnaires and implantable devices data |
A Tsarouchas, C Bakogiannis, D Mouselimis, C Lazaridis, I Kelemanis, EK Theofillogiannakos, ED Pagourelias, CE Papadopoulos, N Fragakis, VP Vassilikos |
| 97 |
[GO] |
2021―May―11 |
An indian clinician outlook on hypertension care during Covid-19 pandemic |
M Abhyankar, B Majumder, DK Agarwal, KA Amarnath, MUKESH Jha, BK Kumar, S Revankar, SILKI Silki, VIJAY Surase |
| 98 |
[GO] |
2021―May―11 |
Impact of lockdown in patients with congestive heart failure during the Covid-19 pandemic |
F Chague, M Boulin, JC Eicher, F Bichat, M Saint-Jalmes, A Cransac-Miet, A Soudry, N Danchin, G Laurent, Y Cottin, M Zeller |
| 99 |
[GO] |
2021―May―11 |
Body composition, lipid profile and mediterranean diet adherence in cardiovascular disease patients attending a long-term exercise-based cardiac rehabilitation program during COVID-19 pandemic |
M Linan Pinto, R Pinto, S Charneca, J Vasques, M Lemos Pires, M Borges, C Rodrigues, P Alves Da Silva, I Ricardo, H Santa-Clara, A Abreu, FJ Pinto, C Sousa Guerreiro |
| 100 |
[GO] |
2021―May―11 |
Pulmonary embolism during the COVID-19 pandemic |
BV Silva, T Rodrigues, N Cunha, J Brito, P Alves Da Silva, P Silverio Antonio, S Couto Pereira, I Aguiar Ricardo, J Rigueira, C Mendonca, A Abreu |
| 101 |
[GO] |
2021―May―11 |
Remotely monitored cardiac rehabilitation based on a walking test during the COVID-19 pandemic |
L Batalik, F Dosbaba, V Konecny, K Batalikova |
| 102 |
[GO] |
2021―May―11 |
Exercise-based cardiac rehabilitation adaptation protocol during COVID-19 pandemic achieved similar results as compared to non-pandemic usual practice: a single-center retrospective study |
AB Hartopo, ZH Islami, IA Arso, AM Ambari, B Dwiputra, B Radi |
| 103 |
[GO] |
2021―May―11 |
Web discussions on cardiovascular diseases: assessing the impact of COVID-19 pandemic. An Italian prospective analysis |
P Magni, I Cecchini, M Fortunati, M Biroli, K Massaroni, E Folco, D Giudice, M Montebelli, G Ciancamerla |
| 104 |
[GO] |
2021―May―11 |
Effects of COVID-19 pandemic on physical activity: Results of the Russian online survey on spring 2020 |
A Kontsevaya, D Mukaneeva, A Myrzamatova, M Khudyakov, O Drapkina |
| 105 |
[GO] |
2021―May―11 |
COVID-19 pandemic stresses trigger ST-elevation and non-ST-elevation acute myocardial infarction in Middle Eastern individuals not infected with the virus |
A Hammoudeh, E Mdanat, R Tabbalat, M Jarrah, IA Alhaddad |
| 106 |
[GO] |
2021―May―11 |
Home-based cardiac rehabilitation during COVID-19 pandemic: effectiveness of an educational intervention |
BV Silva, I Aguiar Ricardo, P Alves Da Silva, T Rodrigues, N Cunha, S Couto Pereira, P Silverio Antonio, J Brito, R Pinto, M Lemos Pires, S Fiuza, AL Correia, F J Pinto, A Abreu |
| 107 |
[GO] |
2021―May―11 |
Digital home-based multidisciplinary cardiac rehabilitation: the way to counteract physical inactivity during the COVID-19 pandemic? |
R Pinto, M Lemos Pires, M Borges, M Linan Pinto, C Sousa Guerreiro, S Miguel, O Santos, M Ramalhinho, S Fiuza, M Cordeiro Ferreira, I Ricardo, N Cunha, P Alves Da Silva, FJ Pinto, A Abreu |
| 108 |
[GO] |
2021―May―11 |
ECG markers of malignant arrhythmias risk in patients with arterial hypertension hospitalized for COVID-19 pneumonia |
A Novitskiy, K Popov, A Smirnova, Y Shvarts |
| 109 |
[GO] |
2021―May―11 |
Smoking and associated unhealthy lifestyle behaviours in patients with chronic cardiac diseases during COVID-19 related lockdown |
F Chague, M Boulin, JC Eicher, F Bichat, M Saint-Jalmes, A Cransac-Miet, B Trojak, A Soudry, N Danchin, G Laurent, Y Cottin, M Zeller |
| 110 |
[GO] |
2021―May―11 |
Home blood pressure during COVID-19 related lockdown in patients with hypertension |
M Pengo, F Albini, G Guglielmi, C Mollica, D Soranna, G Zambra, A Zambon, G Bilo, G Parati |
| 111 |
[GO] |
2021―May―11 |
Cardiac rehabilitation and secondary prevention in COVID-19 times: Single center experience |
I Burazor, DS Spiroski, J Terzic, P Otasevic, R Babic, A Nikolic, I Ilic, G Loncar, Z Cosic, M Colic, B Rihor, M Andjic, M Bojic, D Davos |
| 112 |
[GO] |
2021―May―11 |
Adherence to remote cardiac rehabilitation during the coronavirus pandemic |
I Nabutovsky, Y Klempfner, A Nachshon, S Yeshayahu, D Breitner, A Heller, R Klempfner |
| 113 |
[GO] |
2021―May―11 |
Impact of an online cardiac rehabilitation program after an acute coronary syndrome during SARS-CoV-2 pandemic |
A Severo Sanchez, B Rivero Santana, E Arbas Redondo, VM Juarez Olmos, D Poveda Pinedo, D Tebar Marquez, R Dalmau Gonzalez-Galarza, A Castro Conde |
| 114 |
[GO] |
2020―Aug―06 |
CORRIGENDUM: Editor’s presentation: ‘Les liaisones dangerouses. The heart in the time of COVID-19’ |
|
| 115 |
[GO] |
2020―Jul―08 |
The morbidity and mortality of COVID-19 are associated with ABO and Rh blood groups |
Maryam Ansari-Lari, Mostafa Saadat |
| 116 |
[GO] |
2020―Jul―08 |
Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy |
Geza Halasz, Matteo LG Leoni, Giovanni Quinto Villani, Massimo Nolli, Matteo Villani |
| 117 |
[GO] |
2020―Jul―03 |
The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology |
Martijn Scherrenberg, Matthias Wilhelm, Dominique Hansen, Heinz Völler, Véronique Cornelissen, Ines Frederix, Hareld Kemps, Paul Dendale |
| 118 |
[GO] |
2020―Jun―25 |
Editor’s presentation: ‘Les liaisones dangerouses. The heart in the time of COVID-19’ |
Massimo F Piepoli |
| 119 |
[GO] |
2020―Jun―17 |
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead |
Francesco Gentile, Alberto Aimo, Francesco Forfori, Giosuè Catapano, Alberto Clemente, Filippo Cademartiri, Michele Emdin, Alberto Giannoni |
| 120 |
[GO] |
2020―Jun―16 |
Sport and exercise during and beyond the COVID-19 pandemic |
Tee Joo Yeo |
| 121 |
[GO] |
2020―Jun―10 |
C3 polymorphisms represent an important immunological confounder on the spread and outcome of COVID-19 |
Xiaofeng Dai |
| 122 |
[GO] |
2020―Jun―01 |
Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC) |
Raghav T Bhatia, Sarandeep Marwaha, Aneil Malhotra, Zafar Iqbal, Christopher Hughes, Mats Börjesson, Josef Niebauer, Antonio Pelliccia, Christian Schmied, Luis Serratosa, Michael Papadakis, Sanjay Sharma |
| 123 |
[GO] |
2020―May―28 |
Cardiology practice in the COVID-19 era |
Jean-Jacques Monsuez |
| 124 |
[GO] |
2020―May―28 |
C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism |
Joris R Delanghe, Marc L De Buyzere, Marijn M Speeckaert |
| 125 |
[GO] |
2020―May―28 |
Traffic-related air pollution and the coronavirus pandemia: shadows and lights |
Pier Mannuccio Mannucci |
| 126 |
[GO] |
2020―May―19 |
Physical activity/inactivity and COVID-19 |
Antonio Crisafulli, Pasquale Pagliaro |
| 127 |
[GO] |
2020―May―19 |
Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS |
Bo Li, Xiaodong Jin, Tongtong Zhang, Yan Zhao, Feng Tian, Yuhua Li, Jing Yang, Faming Zhao, Bin Li |
| 128 |
[GO] |
2020―May―19 |
Effect of coronavirus infection on the human heart: A scoping review |
Jamie SY Ho, Paul A Tambyah, Andrew FW Ho, Mark YY Chan, Ching-Hui Sia |
| 129 |
[GO] |
2020―May―16 |
Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-19 |
Piergiuseppe Agostoni, Massimo Mapelli, Edoardo Conte, Andrea Baggiano, Emilio Assanelli, Anna Apostolo, Marina Alimento, Giovanni Berna, Marco Guglielmo, Manuela Muratori, Francesca Susini, Pietro Palermo, Beatrice Pezzuto, Elisabetta Salvioni, Anna Sudati, Carlo Vignati, Luca Merlino |
| 130 |
[GO] |
2020―May―13 |
Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19 |
Edoardo Sciatti, Claudio Ceconi |
| 131 |
[GO] |
2020―May―11 |
Cardiovascular disease and COVID-19: les liaisons dangereuses |
Andrea Barison, Alberto Aimo, Vincenzo Castiglione, Chiara Arzilli, Josep Lupón, Pau Codina, Evelyn Santiago-Vacas, Germán Cediel, Michele Emdin, Antoni Bayes-Genis |
| 132 |
[GO] |
2020―Apr―28 |
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases |
Xiaofeng Dai |
| 133 |
[GO] |
2020―Apr―23 |
Future-proofing cardiac rehabilitation: Transitioning services to telehealth during COVID-19 |
Emma Thomas, Robyn Gallagher, and Sherry L Grace |
| 134 |
[GO] |
2020―Apr―17 |
Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia |
Bernhard Rauch |
| 135 |
[GO] |
2020―Apr―16 |
Amiodarone as a possible therapy for coronavirus infection |
Alberto Aimo, Aldo Baritussio, Michele Emdin, Carlo Tascini |
| 136 |
[GO] |
2020―Apr―15 |
Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers |
Riccardo Sarzani, Federico Giulietti, Chiara Di Pentima, Piero Giordano, Francesco Spannella |
| 137 |
[GO] |
2020―Apr―09 |
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19) |
Giuseppe Lippi, Brandon M Henry, Fabian Sanchis-Gomar |
| 138 |
[GO] |
2020―Apr―03 |
A dialogue between the editor-in-chief and a deputy editor of a cardiology journal during the coronavirus outbreak: Take-home messages from the Italian experience |
Massimo F Piepoli, Michele Emdin |
| 139 |
[GO] |
2020―Apr―03 |
2019 CORONAVIRUS: What are the implications for cardiology? |
R Ferrari, G Di Pasquale, C Rapezzi |
| 140 |
[GO] |
2020―Apr―01 |
Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic |
Tee Joo Yeo, Yi-Ting Laureen Wang, Ting Ting Low |
|
